Published in Stem Cells Int on May 07, 2012
Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis. Biomed Res Int (2013) 1.19
Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis. Stem Cell Res Ther (2014) 0.98
Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells. Exp Mol Med (2014) 0.94
Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System. Cytotherapy (2013) 0.90
A modified method for isolation of bladder cancer stem cells from a MB49 murine cell line. BMC Urol (2013) 0.88
Mesenchymal Stem Cells Derived from Dental Pulp: A Review. Stem Cells Int (2015) 0.86
Comparison of proliferative and multilineage differentiation potential of sheep mesenchymal stem cells derived from bone marrow, liver, and adipose tissue. Avicenna J Med Biotechnol (2013) 0.85
Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative study. Stem Cell Res Ther (2014) 0.83
Optimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cells. Int J Biol Sci (2015) 0.81
Strategies to improve the immunosuppressive properties of human mesenchymal stem cells. Stem Cell Res Ther (2015) 0.80
Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model. Stem Cell Res Ther (2017) 0.80
Expression of bone morphogenetic protein-6 in dental follicle stem cells and its effect on osteogenic differentiation. Cells Tissues Organs (2014) 0.79
Human mesenchymal stem cells possess different biological characteristics but do not change their therapeutic potential when cultured in serum free medium. Stem Cell Res Ther (2014) 0.77
A Detailed Assessment of Varying Ejection Rate on Delivery Efficiency of Mesenchymal Stem Cells Using Narrow-Bore Needles. Stem Cells Transl Med (2016) 0.76
Low-density subculture: a technical note on the importance of avoiding cell-to-cell contact during mesenchymal stromal cell expansion. J Tissue Eng Regen Med (2015) 0.76
Manufacturing of dental pulp cell-based products from human third molars: current strategies and future investigations. Front Physiol (2015) 0.76
Healing of a Large Long-Bone Defect through Serum-Free In Vitro Priming of Human Periosteum-Derived Cells. Stem Cell Reports (2017) 0.75
Quick and effective method of bone marrow mesenchymal stem cell extraction. Open Med (Wars) (2014) 0.75
Attachment, Growth, and Detachment of Human Mesenchymal Stem Cells in a Chemically Defined Medium. Stem Cells Int (2016) 0.75
Using Stem Cells to Grow Artificial Tissue for Peripheral Nerve Repair. Stem Cells Int (2016) 0.75
Decellularized extracellular matrices produced from immortal cell lines derived from different parts of the placenta support primary mesenchymal stem cell expansion. PLoS One (2017) 0.75
Generation of induced pluripotent stem cells from human mesenchymal stem cells of parotid gland origin. Am J Transl Res (2016) 0.75
Generating Peripheral Blood Derived Lymphocytes Reacting Against Autologous Primary AML Blasts. J Immunother (2016) 0.75
Two Bioactive Molecular Weight Fractions of a Conditioned Medium Enhance RPE Cell Survival on Age-Related Macular Degeneration and Aged Bruch's Membrane. Transl Vis Sci Technol (2016) 0.75
Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction. Stem Cell Res Ther (2017) 0.75
Titanium phosphate glass microcarriers induce enhanced osteogenic cell proliferation and human mesenchymal stem cell protein expression. J Tissue Eng (2015) 0.75
Human Bone Marrow Mesenchymal Stem/Stromal Cells Preserve Their Immunomodulatory and Chemotactic Properties When Expanded in a Human Plasma Derived Xeno-Free Medium. Stem Cells Int (2017) 0.75
Insulin Promotes the Proliferation of Human Umbilical Cord Matrix-Derived Mesenchymal Stem Cells by Activating the Akt-Cyclin D1 Axis. Stem Cells Int (2017) 0.75
Microcarriers with Synthetic Hydrogel Surfaces for Stem Cell Expansion. Adv Healthc Mater (2017) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood (2004) 13.79
Mesenchymal stem cells in health and disease. Nat Rev Immunol (2008) 11.14
Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells (2006) 8.61
Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci (2006) 8.09
Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell (2009) 7.62
Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol (2007) 6.63
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A (2002) 6.05
Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy (2005) 5.92
Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells (2002) 4.62
Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone (2003) 4.61
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol (2005) 4.27
Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol (1999) 4.08
Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies. Stem Cells (2007) 3.99
Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood (1980) 3.51
Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A (2006) 3.48
Aging of mesenchymal stem cell in vitro. BMC Cell Biol (2006) 3.32
Methods for growth of cultured cells in serum-free medium. Anal Biochem (1980) 3.27
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res (2007) 3.19
Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med (2007) 3.02
Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med (2010) 2.86
Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A (2010) 2.74
Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol (2003) 2.65
Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells (2007) 2.46
Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther (2004) 2.35
In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells (2005) 2.33
FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol (2005) 2.31
Lessons from basic research in selenium and cancer prevention. J Nutr (1998) 2.27
Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol (2005) 2.26
Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun (2001) 2.24
Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion (2007) 2.20
Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells (2009) 2.19
Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells (2007) 2.09
Partial replacement of serum by selenite, transferrin, albumin and lecithin in haemopoietic cell cultures. Nature (1976) 2.02
Immune modulation by mesenchymal stem cells. Exp Cell Res (2006) 1.99
Selenium is an essential trace nutrient for growth of WI-38 diploid human fibroblasts. Proc Natl Acad Sci U S A (1976) 1.98
Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells (2007) 1.85
"Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin Pharmacol Ther (2007) 1.85
Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev (2008) 1.74
Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods (2008) 1.73
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy (2006) 1.64
Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp Hematol (2008) 1.63
Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro. Cytotherapy (2009) 1.57
Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med (2007) 1.57
The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy (2008) 1.52
Effect of heparin on vascular smooth muscle cells. I. Cell metabolism. J Cell Physiol (1985) 1.50
Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol (2004) 1.49
Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol (1997) 1.45
Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr Opin Immunol (2006) 1.44
Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol (2007) 1.42
Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. Int J Dev Biol (2008) 1.42
A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One (2010) 1.39
Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A (2010) 1.38
Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev (2007) 1.36
The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood (1995) 1.32
Modulation of immune responses by mesenchymal stem cells. Ann N Y Acad Sci (2007) 1.30
A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res (1995) 1.26
Two steps to functional mesenchymal stromal cells for clinical application. Transfusion (2007) 1.23
Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets (2004) 1.21
Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev (2008) 1.20
Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo. Stem Cells (2007) 1.20
Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant (2007) 1.19
"Humanized" stem cell culture techniques: the animal serum controversy. Stem Cells Int (2011) 1.18
Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol (2010) 1.16
UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy (2007) 1.16
Stem cells: potential therapy for age-related diseases. Ann N Y Acad Sci (2006) 1.15
Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol Int (2008) 1.13
Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation. Transplantation (2000) 1.09
Improving the expansion and neuronal differentiation of mesenchymal stem cells through culture surface modification. Biomaterials (2003) 1.09
Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: potential feasibility for clinical applications. Cell Transplant (2008) 1.07
Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. Eur J Immunol (2011) 1.07
Low serum and serum-free culture of multipotential human adipose stem cells. Cytotherapy (2007) 1.07
Feasibility and efficacy of bone tissue engineering using human bone marrow stromal cells cultivated in serum-free conditions. Biochem Biophys Res Commun (2009) 1.04
Clinical grade production of mesenchymal stem cells. Biomed Mater Eng (2008) 1.03
Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties. J Immunol Methods (2010) 1.02
Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun (2007) 1.02
Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow. Cytotherapy (2009) 1.00
Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum. Transplantation (2007) 0.99
Growth factor-defined culture medium for human mesenchymal stem cells. Int J Dev Biol (2011) 0.97
Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate. J Clin Immunol (2011) 0.96
Suitability of human mesenchymal stem cells for gene therapy depends on the expansion medium. Exp Cell Res (2008) 0.95
Human umbilical cord blood serum promotes growth, proliferation, as well as differentiation of human bone marrow-derived progenitor cells. In Vitro Cell Dev Biol Anim (2007) 0.95
Retracted IFATS collection: Selenium induces improvement of stem cell behaviors in human adipose-tissue stromal cells via SAPK/JNK and stemness acting signals. Stem Cells (2008) 0.95
Determination of L-ascorbic acid levels in culture medium: concentrations in commercial media and maintenance of levels under conditions of organ culture. In Vitro (1977) 0.93
MSCs in hematopoietic cell transplantation. Biol Blood Marrow Transplant (2011) 0.93
Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media. Cytotherapy (2009) 0.92
Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells (2006) 0.92
Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher self-renewal and enhanced osteogenic potential. Stem Cells Dev (2009) 0.90
Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells. Cytotherapy (2010) 0.90
Human mesenchymal stem cells respond to fibroblast growth factors. Hum Cell (1997) 0.89
Xeno-free proliferation of human bone marrow mesenchymal stem cells. Cytotechnology (2011) 0.89
Development of improved media and culture conditions for clonal growth of normal diploid cells. In Vitro (1978) 0.88
Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures. Cell Biol Int (2006) 0.88
Safety of bovine sera for production of mesenchymal stem cells for therapeutic use. Hum Gene Ther (2011) 0.87
High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferation. Am J Physiol Regul Integr Comp Physiol (2009) 0.87
A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo- and chondrogenic precursors. Stem Cells Dev (2010) 0.86
Differences in growth response to hydrocortisone and ascorbic acid by human diploid fibroblasts. In Vitro (1977) 0.83
Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology (2003) 2.76
Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells. Diabetes (2009) 1.60
{beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes. Endocrinology (2010) 1.32
Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology (2004) 1.29
Donor and isolation variables predicting human islet isolation success. Transplantation (2008) 1.08
Tubular complexes as a source for islet neogenesis in the pancreas of diabetes-prone BB rats. Lab Invest (2005) 1.03
New tissue dissociation protocol for scaled-up production of neural stem cells in suspension bioreactors. Tissue Eng (2004) 1.03
Spinal GABAergic transplants attenuate mechanical allodynia in a rat model of neuropathic pain. Stem Cells (2007) 1.01
Scale-up of breast cancer stem cell aggregate cultures to suspension bioreactors. Biotechnol Prog (2006) 0.99
The effect of extracellular matrix components on the preservation of human islet function in vitro. Biomaterials (2009) 0.99
Long-term in vitro human pancreatic islet culture using three-dimensional microfabricated scaffolds. Biomaterials (2010) 0.94
Amyloid inhibitors enhance survival of cultured human islets. Biochim Biophys Acta (2009) 0.94
Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture. Diabetes (2008) 0.93
Acinar plasticity: development of a novel in vitro model to study human acinar-to-duct-to-islet differentiation. Pancreas (2007) 0.92
Cell cycle kinetics of expanding populations of neural stem and progenitor cells in vitro. Biotechnol Bioeng (2004) 0.91
The engineering of tissues using progenitor cells. Curr Top Dev Biol (2004) 0.91
Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells. Cytotherapy (2010) 0.90
Large-scale production of human mesenchymal stem cells for clinical applications. Biotechnol Appl Biochem (2013) 0.89
Using simulation to determine the need for ICU beds for surgery patients. Surgery (2009) 0.89
Tumor necrosis factor-alpha production by human islets leads to postisolation cell death. Transplantation (2006) 0.88
Integrin {alpha}3, but not {beta}1, regulates islet cell survival and function via PI3K/Akt signaling pathways. Endocrinology (2010) 0.88
INGAP peptide improves nerve function and enhances regeneration in streptozotocin-induced diabetic C57BL/6 mice. FASEB J (2004) 0.87
Expansion of mammalian neural stem cells in bioreactors: effect of power input and medium viscosity. Brain Res Dev Brain Res (2002) 0.87
Scaled-up production of mammalian neural precursor cell aggregates in computer-controlled suspension bioreactors. Biotechnol Bioeng (2006) 0.84
Morphological and functional studies on submucosal islet transplants in normal and diabetic hamsters. Cell Transplant (2002) 0.84
Cellular origins of adult human islet in vitro dedifferentiation. Lab Invest (2008) 0.83
Expansion of human neural precursor cells in large-scale bioreactors for the treatment of neurodegenerative disorders. Biotechnol Prog (2009) 0.83
The role of islet neogenesis-associated protein (INGAP) in islet neogenesis. Cell Biochem Biophys (2007) 0.83
Enhanced islet expansion by beta-cell proliferation in young diabetes-prone rats fed a protective diet. J Cell Physiol (2010) 0.83
Human mesenchymal stem cell culture: rapid and efficient isolation and expansion in a defined serum-free medium. J Tissue Eng Regen Med (2011) 0.83
Identification and characterization of small cells in the adult pancreas: potential progenitor cells? Cell Tissue Res (2002) 0.83
Dynamic behavior of cells within neurospheres in expanding populations of neural precursors. Brain Res (2006) 0.82
Pancreatic islet culture and preservation strategies: advances, challenges, and future outlook. Cell Transplant (2010) 0.82
A review of bioreactor protocols for human neural precursor cell expansion in preparation for clinical trials. Curr Stem Cell Res Ther (2011) 0.82
Transforming growth factor beta is a critical regulator of adult human islet plasticity. Mol Endocrinol (2007) 0.81
Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation. Stem Cell Rev (2015) 0.80
Large-scale expansion of mammary epithelial stem cell aggregates in suspension bioreactors. Biotechnol Prog (2005) 0.80
Production of islet-like structures from neonatal porcine pancreatic tissue in suspension bioreactors. Biotechnol Prog (2006) 0.79
Bioreactor expansion of human neural precursor cells in serum-free media retains neurogenic potential. Biotechnol Bioeng (2010) 0.79
Passaging protocols for mammalian neural stem cells in suspension bioreactors. Biotechnol Prog (2002) 0.78
Design and analysis of a long-term live-cell imaging chamber for tracking cellular dynamics within cultured human islets of Langerhans. Biotechnol Bioeng (2007) 0.78
Epidermal growth factor induces adult human islet cell dedifferentiation. J Endocrinol (2011) 0.78
Insulin-like growth factor II allows prolonged blood glucose normalization with a reduced islet cell mass transplantation. Endocrinology (2003) 0.78
Islet-neogenesis-associated protein enhances neurite outgrowth from DRG neurons. Biochem Biophys Res Commun (2002) 0.78
Islet-derived progenitors as a source of in vitro islet regeneration. Methods Mol Biol (2009) 0.78
Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein. J Diabetes Sci Technol (2007) 0.78
Neurite outgrowth in dorsal root ganglia induced by islet neogenesis-associated protein peptide involves protein kinase A activation. Neuroreport (2006) 0.78
Inhibition of caspase-mediated PARP-1 cleavage results in increased necrosis in isolated islets of Langerhans. J Mol Med (Berl) (2004) 0.78
Islet neogenesis: a potential therapeutic tool in type 1 diabetes. Int J Biochem Cell Biol (2005) 0.78
Dielectric spectroscopy for non-invasive monitoring of epithelial cell differentiation within three-dimensional scaffolds. Phys Med Biol (2012) 0.77
Transplantation of GABAergic cells derived from bioreactor-expanded human neural precursor cells restores motor and cognitive behavioral deficits in a rodent model of Huntington's disease. Cell Transplant (2012) 0.77
Bioprocessing of human glioblastoma brain cancer tissue. Tissue Eng Part A (2010) 0.77
Production and characterization of the recombinant Islet Neogenesis Associated Protein (rINGAP). Protein Expr Purif (2009) 0.76
Characterization of human islet-like structures generated from pancreatic precursor cells in culture. Biotechnol Bioeng (2006) 0.76
Development of an in vitro pancreatic tissue model to study regulation of islet neogenesis associated protein expression. J Endocrinol (2006) 0.76
Block-copolymer micelles as carriers of cell signaling modulators for the inhibition of JNK in human islets of Langerhans. Biomaterials (2009) 0.76
New bioengineering insights into human neural precursor cell expansion in culture. Biotechnol Prog (2011) 0.76
Survival, differentiation, and migration of bioreactor-expanded human neural precursor cells in a model of Parkinson disease in rats. Neurosurg Focus (2008) 0.76
The identification and sequence analysis of a new Reg3gamma and Reg2 in the Syrian golden hamster. Biochim Biophys Acta (2007) 0.76
Mechanisms of action of islet neogenesis-associated protein: comparison of the full-length recombinant protein and a bioactive peptide. Am J Physiol Endocrinol Metab (2012) 0.75
Optimization of reovirus production from mouse L-929 cells in suspension culture. Biotechnol Bioeng (2004) 0.75